FDA Requests Comments on Safety Labeling Draft Guidance for Drugs and Biologics
The Food and Drug Administration is announcing the availability of a draft guidance for industry entitled “Safety Labeling Changes - Implementation of Section 505(o)(4) of the Federal Food, Drug, and Cosmetic Act.” This draft guidance for certain drugs and biologic…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
products provides information on the implementation of new provisions, including a description of the types of safety labeling changes that ordinarily might be required under the new legislation; how FDA plans to determine what constitutes new safety information; the procedures involved in requiring safety labeling changes, and enforcement of the requirements for safety labeling changes. Comments are due by July 12, 2011.